系统的网络药理学和实验验证揭示了通过多目标调节通过光皮的抗质瘤机制
Xue Mei1, Jufen Zhang1, Lu Chen1
1Chinese 904th Hospital of the Joint Logistics Support Force of the People's Liberation Army, Wuxi, Jiangsu, China.
Discover oncology
|August 4, 2025
概括
清白 (Lingzhi) 显示出对抗致命的脑癌质瘤的潜力. 网络药理学确定了β-Sitosterol作为一种关键化合物,抑制了质瘤细胞的生长和侵入,为新疗法提供了基础.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 传统中国医药 传统中国医药
背景情况:
- 质瘤是一种致命的原发性脑瘤,治疗选择有限.
- 传统中医 (TCM) 提供复杂疾病的多目标药物.
- 光 (Lingzhi) 具有抗瘤作用,但其质瘤机制尚不清楚.
研究的目的:
- 通过网络药理学研究Ganoderma的活性化合物和针对质瘤的点.
- 确定关键的分子机制并验证治疗潜力.
主要方法:
- 使用公共数据库 (TCMSP,SwissTargetPrediction,GeneCards,DisGeNET) 的网络药理方法.
- 基因本体学 (GO) 和KEGG通路丰富分析.
- 蛋白与蛋白相互作用 (PPI) 网络的构建和枢纽基因的识别.
- 对目标相关性进行TCGA和HPA数据集验证.
- 分子对接和体外抗质瘤测定Beta-Sitosterol.
主要成果:
- 确定了16种活性化合物和86种与质瘤相关的点.
- 发现涉及类固醇代谢,GPCR信号传递和神经活性联体受体相互作用.
- 已经确定并验证了七个枢纽基因 (CASP3,PTGS2,HIF1A,BCL2,ESR1,MDM2,PPARG).
- 贝塔-西托醇与CASP3和PTGS2强烈结合,抑制了质瘤细胞活力,殖民地形成,入侵和迁移.
结论:
- 甘菌通过多目标,多途径机制对质瘤施加治疗作用.
- 贝塔-固醇显示出显著的抗质瘤潜力.
- 提供了科学基础,用于开发新的补充疗法从甘菌.
相关概念视频
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
G Protein-coupled Receptors
13.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.4K


